Malintad, Baby Girl 2 .
HRN: 25-13-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/22/2024
05/28/2024
5
30mg
Q24
Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes